Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-17

Clinical Trial Update: Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation? [Phase 4]

View source ↗

Summary

Phase 4 Mayo Clinic trial evaluating whether intensive acid suppression reduces esophageal inflammation and recurrence of Barrett's esophagus after ablation; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proton Pump Inhibitor (proton pump inhibitor)

Snippet

Sponsor: Mayo Clinic | Conditions: Inflammation, Barrett's Esophagus | Phase 4 | Status: COMPLETED | Results posted: 2016-03-17